Stocktoria
AGENUS INC AGEN
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2000-02-04
AGENUS INC statistics & valuation
Market cap$126.2M
P / S1.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -17.7% | -116.4% | -102.1% | -183.0% | 8.7% |
| FCF margin | -67.6% | -153.6% | -149.8% | -233.0% | -8.0% |
| Debt / equity | -0.16× | -0.10× | -0.08× | -0.21× | 0.27× |
| Current ratio | 0.41 | 0.21 | 0.44 | 1.13 | 2.12 |
| Revenue growth | 10.4% | -33.8% | 59.5% | -66.8% | 235.3% |
Source: SEC EDGAR filings · CIK 0001098972 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.